🇺🇸 FDA
Pipeline program

Aldurazyme

ALID-006-01

Phase 3 mab completed

Quick answer

Aldurazyme for Mucopolysaccharidosis I is a Phase 3 program (mab) at BIOMARIN PHARMACEUTICAL INC with 1 ClinicalTrials.gov record(s).

Program details

Company
BIOMARIN PHARMACEUTICAL INC
Indication
Mucopolysaccharidosis I
Phase
Phase 3
Modality
mab
Status
completed

Clinical trials